Automated Suturing Devices Market Insights, Competitive Landscape and Market Forecast-2034

Published Date : 2026
Pages : 150
Region : Global,
Delivery Timeline : 24 Hours

Automated Suturing Devices Market Summary

● The Automated Suturing Devices market is estimated at USD 4.23 billion in 2025 and is projected to reach USD 7.98 billion by 2034. Growth is anchored in the rising global volume of surgical procedures, accelerating adoption of minimally invasive and robotic-assisted surgery, and increasing demand for consistent, efficient wound closure across cardiovascular, gastrointestinal, and orthopedic procedures.

● The global Automated Suturing Devices market is growing at a CAGR of 7.34% during the forecast period from 2026 to 2034.

● By product type, the disposable segment dominated the Automated Suturing Devices market with a 65% share in 2025.

● By suture type, the absorbable sutures segment dominated the Automated Suturing Devices market with a 58% share in 2025.

● By application, the cardiovascular segment dominated the Automated Suturing Devices market with a 34% share in 2025.

● By end-user, the hospital & clinics segment dominated the Automated Suturing Devices market with a 68% share in 2025.

● North America dominated the global Automated Suturing Devices market revenue with a 45% share in 2025, representing the highest regional market share globally.

An automated suturing device is a surgical instrument or robotic-assisted system that mechanically places, ties, and secures sutures during open, laparoscopic, or minimally invasive procedures, reducing reliance on manual hand-tied knots and improving the consistency, speed, and precision of wound closure. Because manual suturing is time-intensive, technique-dependent, and a contributor to surgeon fatigue during long or complex procedures, hospitals and ambulatory surgical centers are increasingly adopting automated and robotic-assisted suturing platforms across cardiovascular, gynecological, gastrointestinal, and orthopedic surgery. These devices span disposable, single-use instruments designed to minimize infection risk and eliminate reprocessing, and reusable systems suited to high-volume surgical centers, and they are compatible with both absorbable sutures for temporary internal wound support and non-absorbable sutures for long-term tissue approximation. The market is organized by product type across disposable and reusable devices; by suture type across absorbable and non-absorbable sutures; by application, led by cardiovascular surgery alongside gynecological, gastrointestinal, and orthopedic procedures; and by end-user across hospitals & clinics and ambulatory surgical centers. Driven by rising global surgical volumes, the shift toward minimally invasive and robotic-assisted surgery, and growing demand for consistent, efficient wound closure, automated suturing devices have become an increasingly important component of modern operating-room infrastructure.

Automated Suturing Devices Market Key Growth Drivers

• The rising global volume of surgical procedures, particularly in cardiovascular, gastrointestinal, and orthopedic surgery, is driving demand.

• The growing prevalence of cardiovascular and chronic diseases, together with an aging global population requiring surgical intervention, is expanding demand for consistent, reliable wound-closure technology.

• Hospitals and ambulatory surgical centers are increasingly adopting automated and robotic-assisted suturing platforms to reduce operating time, minimize surgeon fatigue, and improve procedural accuracy.

• The accelerating shift from open surgery to minimally invasive and robotic-assisted procedures is increasing demand for automated suturing devices compatible with laparoscopic and robotic platforms.

• Rising adoption of disposable, single-use suturing devices to minimize infection risk and eliminate reprocessing costs is expanding the addressable market across high-volume surgical settings.

• Strategic product launches, regulatory clearances, and expanding portfolios from leading device manufacturers are broadening clinical adoption across cardiovascular, gynecological, gastrointestinal, and orthopedic applications.

• The convergence of rising surgical volumes, minimally invasive adoption, and robotic-assisted innovation is expected to sustain steady growth in the market through 2034.

Key Companies in Automated Suturing Devices Market

The competitive landscape is led by the following active manufacturers:

• Medtronic

• LSI Solutions, Inc.

• Sutrue Limited

• Apollo Endosurgery, Inc.

• B. Braun Melsungen AG

• Becton, Dickinson & Company

• Ethicon, Inc. (Johnson & Johnson)

• Smith & Nephew, Inc.

• EndoEvolution, LLC.

• Mellon Medical B.V.

Factors Contributing to the Growth of the Automated Suturing Devices Market

Market Drivers

Rising Global Volume of Surgical Procedures and Minimally Invasive Adoption

The most significant driver of the Automated Suturing Devices market is the steadily rising global volume of surgical procedures combined with the accelerating shift from open surgery to minimally invasive and robotic-assisted techniques. Automated suturing devices enable faster, more consistent wound closure during laparoscopic, robotic, and open procedures, reducing operating time and variability compared with hand-tied sutures. As healthcare systems worldwide perform a growing number of cardiovascular, gastrointestinal, orthopedic, and gynecological surgeries each year, and as minimally invasive approaches become the preferred standard of care in eligible cases, demand for compatible automated and robotic-assisted suturing instruments rises directly, anchoring market growth through 2034.

Growing Burden of Cardiovascular, Orthopedic, and Chronic Disease

The rising global burden of cardiovascular disease, musculoskeletal disorders, and other chronic conditions requiring surgical intervention is expanding demand for reliable wound-closure technology. An aging global population is undergoing a growing number of cardiac, orthopedic, and gastrointestinal procedures, and automated suturing devices support the precision and consistency these often complex, high-risk operations require. Cardiovascular surgery in particular depends on secure, reproducible suture lines, and rising rates of coronary and structural heart disease are sustaining strong demand for automated suturing systems across this leading application segment. As chronic disease prevalence continues to climb worldwide, the volume of surgical interventions supported by automated suturing technology is set to expand steadily across the forecast period.

Market Restraints

Despite strong momentum, the Automated Suturing Devices market faces material constraints. The high cost of automated and robotic-assisted suturing devices relative to conventional manual suturing instruments is a significant barrier, particularly for smaller hospitals, ambulatory surgical centers, and providers in developing and low-income regions with constrained capital budgets. Limited adoption and awareness in emerging markets, combined with the need for specialized surgeon training on automated and robotic-assisted platforms, can slow clinical uptake and extend purchasing decision cycles. Reusable devices carry additional reprocessing, sterilization, and maintenance requirements that add operational complexity, while reimbursement frameworks for automated suturing procedures remain uneven across geographies and can affect adoption pace. Stringent regulatory clearance requirements across major markets lengthen product development and launch timelines, and the availability of established, lower-cost manual suturing alternatives continues to compete for surgeon preference in routine, lower-complexity procedures. Together, these cost, training, reimbursement, and regulatory barriers temper the pace of growth, even as the underlying drivers of rising surgical volumes, minimally invasive adoption, and robotic-assisted innovation remain firmly intact.

Automated Suturing Devices Market Segment Analysis

The Automated Suturing Devices Market by product type (disposable, reusable), suture type (absorbable sutures, non-absorbable sutures), application (cardiovascular, gynecological, gastrointestinal, orthopedic, others), end-user (hospital & clinics, ambulatory surgical centers, others), and geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Disposable.

The disposable segment accounted for 65% of the Automated Suturing Devices market in 2025. Disposable devices are the leading product type because single-use instruments eliminate the risk of cross-contamination and reprocessing failures, satisfy increasingly stringent hospital infection-control protocols, and remove the sterilization burden and turnaround delays associated with reusable systems. Their operational simplicity and suitability for fast-paced, high-volume surgical environments make disposable devices the preferred choice across hospitals and ambulatory surgical centers alike, particularly for routine cardiovascular, gastrointestinal, and gynecological procedures. While reusable devices offer lower long-term per-procedure cost and remain attractive to high-volume surgical centers with dedicated sterilization infrastructure, the compliance, convenience, and infection-control advantages of disposables secure the segment's clear leadership across the forecast period.

By Suture Type

Dominant Subsegment: Absorbable Sutures.

The absorbable sutures segment accounted for 58% of the Automated Suturing Devices market in 2025. Absorbable sutures are the leading suture type because they eliminate the need for a follow-up suture-removal visit, reduce long-term infection and irritation risk, and are broadly compatible with internal tissue approximation across cardiovascular, gastrointestinal, and gynecological procedures where the sutured tissue heals without ongoing external tension. Their growing use in internal, minimally invasive, and robotic-assisted procedures, where retrieval of non-absorbable material would be impractical, reinforces the segment's scale. Non-absorbable sutures remain essential for procedures requiring long-term structural support, such as certain orthopedic and cardiovascular applications, but the breadth of internal and minimally invasive use cases keeps absorbable sutures the dominant suture type across the forecast period.

Automated Suturing Devices Market Region Analysis

Dominant Region: North America

North America accounted for 45% of the global Automated Suturing Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a well-developed surgical infrastructure, high adoption of robotic-assisted surgical platforms, a large volume of cardiovascular and orthopedic procedures, and the concentrated presence of leading device manufacturers, including Medtronic, Ethicon, Inc. (Johnson & Johnson), and Becton, Dickinson and Company. The United States drives regional demand through its extensive network of hospitals and ambulatory surgical centers, favorable reimbursement for minimally invasive and robotic-assisted procedures, and continued investment in operating-room technology. Rising rates of cardiovascular and chronic disease, combined with the region's leadership in robotic-assisted surgery adoption, sustain substantial demand for automated suturing devices, anchoring North America's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Automated Suturing Devices market. The region's elevated CAGR is driven by rising surgical volumes, rapid expansion of hospital and ambulatory surgical infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding its network of tertiary hospitals and adopting robotic-assisted surgical platforms at pace; Japan is integrating automated suturing technology into its advanced surgical care system; and India is emerging as a fast-growing market on the back of rising surgical volumes and expanding private hospital infrastructure, while Australia and South Korea are increasing adoption of minimally invasive and robotic-assisted procedures. Growing government healthcare investment, an expanding middle class with rising access to surgical care, and increasing local manufacturing capability are accelerating adoption across the region. The combination of high disease burden, infrastructure build-out, and rising surgical volumes positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 45% of the global Automated Suturing Devices market revenue in 2025. The United States dominates on the strength of its advanced surgical infrastructure, high adoption of robotic-assisted surgery, and the concentrated presence of leading manufacturers, while rising rates of cardiovascular and chronic disease and continued investment in operating-room technology reinforce the region's leadership.

Europe

Europe is a large and advanced regional market, supported by well-established healthcare systems, strong surgical volumes in Germany, France, and the United Kingdom, and growing adoption of minimally invasive and robotic-assisted surgery. The presence of leading manufacturers, including B. Braun Melsungen AG and Mellon Medical B.V., alongside expanding CE-marked device portfolios, reinforces the region's role in both routine and complex surgical applications across Germany, the United Kingdom, France, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising surgical volumes, rapid hospital infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's expanding tertiary-hospital network, Japan's advanced surgical care system, India's rising private-hospital surgical volumes, and growing robotic-assisted adoption in South Korea and Australia are accelerating regional market growth.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital infrastructure, rising demand for minimally invasive and cardiovascular surgical care, and efforts to broaden access to advanced surgical technology are gradually increasing adoption, while growing private-hospital investment and international partnerships support the build-out of regional surgical capacity.

Automated Suturing Devices Market Competitive Landscape

The Automated Suturing Devices market is classified as Moderately Concentrated. A group of large, diversified medical device leaders with broad surgical portfolios and global distribution, including Medtronic, Ethicon, Inc. (Johnson & Johnson), B. Braun Melsungen AG, and Becton, Dickinson & Company, anchor the top tier, while specialized and fast-scaling providers such as LSI Solutions, Sutrue Limited, Apollo Endosurgery, Smith & Nephew, EndoEvolution, and Mellon Medical compete through focused product innovation, niche surgical applications, and targeted geographic expansion, increasing competition in the fastest-growing application and end-user segments.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with large diversified device leaders anchoring the top tier and a growing field of specialized automated suturing innovators.

• Leading players: Medtronic, Ethicon, Inc. (Johnson & Johnson), B. Braun Melsungen AG, and Becton, Dickinson & Company anchor the top tier through broad surgical portfolios and global distribution networks.

• Geographic reach: Leading manufacturers operate extensive global distribution and sales networks spanning hospitals and ambulatory surgical centers across North America, Europe, and Asia-Pacific.

• Product portfolio strength: Top players offer end-to-end suturing solutions spanning disposable and reusable devices compatible with absorbable and non-absorbable sutures across multiple surgical specialties.

• Technology access: Ownership of proprietary automated and robotic-compatible suturing platforms, including handheld and endoscopic suturing systems, is a decisive competitive advantage.

• Strategic partnerships: Tie-ups with robotic surgical platform providers, hospital networks, and surgical training programs extend the reach of automated suturing technology.

• Investment activity: Continued investment in product development and clinical evidence generation is reinforcing competitive positioning among both established and specialized manufacturers.

• Manufacturing capabilities: Precision device engineering, regulatory-compliant manufacturing, and robust quality-control systems are key competitive moats.

• Innovation focus: Robotic-compatible suturing platforms, ergonomic handheld device design, expanded suture-type compatibility, and disposable device innovation.

Automated Suturing Devices Market Recent Developmental Activities

In 2026, Medtronic expanded its automated suturing device portfolio to strengthen its minimally invasive and robotic-assisted surgery offerings and support growing global surgical volumes. Strategic significance: Reinforces Medtronic's position as a leading diversified surgical device manufacturer with broad hospital distribution reach.

In 2026, Ethicon, Inc. (Johnson & Johnson), broadened its wound-closure and automated suturing portfolio to support expanding applications across cardiovascular, gastrointestinal, and gynecological surgery. Strategic significance: Strengthens Ethicon's leadership in surgical wound-closure technology and broadens clinical adoption.

Automated Suturing Devices Market Segmentation

Automated Suturing Devices Market by Product Type

• Disposable

• Reusable

Automated Suturing Devices Market by Suture Type

• Absorbable Sutures

• Non-Absorbable Sutures

Automated Suturing Devices Market by Application

• Cardiovascular

• Gynecological

• Gastrointestinal

• Orthopedic

• Others

Automated Suturing Devices Market by End-Users

• Hospital & Clinics

• Ambulatory Surgical Centers

• Others

Automated Suturing Devices Market by Geography

• North America Automated Suturing Devices Market

▪ United States Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Canada Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Mexico Automated Suturing Devices Market Size in USD million (2023-2034)

• Europe Automated Suturing Devices Market

▪ Germany Automated Suturing Devices Market Size in USD million (2023-2034)

▪ United Kingdom Automated Suturing Devices Market Size in USD million (2023-2034)

▪ France Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Italy Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Spain Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Rest of Europe Automated Suturing Devices Market Size in USD million (2023-2034)

• Asia-Pacific Automated Suturing Devices Market

▪ China Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Japan Automated Suturing Devices Market Size in USD million (2023-2034)

▪ India Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Australia Automated Suturing Devices Market Size in USD million (2023-2034)

▪ South Korea Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Rest of Asia-Pacific Automated Suturing Devices Market Size in USD million (2023-2034)

• Rest of the World (RoW) Automated Suturing Devices Market

▪ Middle East Automated Suturing Devices Market Size in USD million (2023-2034)

▪ Africa Automated Suturing Devices Market Size in USD million (2023-2034)

▪ South America Automated Suturing Devices Market Size in USD million (2023-2034)

Key Takeaways from the Automated Suturing Devices Market Report Study

• Market size analysis for the current Automated Suturing Devices market size (2025), and market forecast for 9 years (2026 to 2034).

• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.

• Key companies dominating the global Automated Suturing Devices market.

• Various opportunities available for competitors in the Automated Suturing Devices market space.

• What are the top-performing segments in 2025? How will these segments perform in 2034?

• Which are the top-performing regions and countries in the current Automated Suturing Devices market scenario?

• Which are the regions and countries where companies should concentrate their opportunities for Automated Suturing Devices market growth in the future?

Target audience who can benefit from this Automated Suturing Devices market report study

• Automated Suturing Devices product providers

• Research organizations and consulting companies

• Automated Suturing Devices -related organizations, associations, forums, and other alliances

• Government and corporate offices

• Start-up companies, venture capitalists, and private equity firms

• Distributors and traders dealing in Automated Suturing Devices 

• Various end-users who want to know more about the Automated Suturing Devices market and the latest technological developments in the Automated Suturing Devices market.

Frequently Asked Questions

The Automated Suturing Devices market is projected to expand at a CAGR of 7.34% during the forecast period from 2026 to 2034.
The Automated Suturing Devices market is estimated at USD 4.23 billion in 2025 and is projected to reach USD 7.98 billion by 2034.
North America dominated the Automated Suturing Devices market with a 45% share of global revenue in 2025, supported by advanced surgical infrastructure, high adoption of robotic-assisted surgery, and the concentrated presence of leading device manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
The principal drivers are the rising global volume of surgical procedures and the shift toward minimally invasive and robotic-assisted surgery; the growing burden of cardiovascular, orthopedic, and chronic disease; increasing adoption of robotic-assisted surgical platforms; rising demand for consistent, efficient wound closure that reduces surgeon fatigue; and the continued expansion of ambulatory surgical center infrastructure.
The major players include Medtronic, LSI Solutions, Inc., Sutrue Limited, Apollo Endosurgery, Inc., B. Braun Melsungen AG, Becton, Dickinson & Company, Ethicon, Inc. (Johnson & Johnson), Smith & Nephew, Inc., EndoEvolution, LLC., and Mellon Medical B.V., among other active manufacturers profiled in the Competitive Landscape section. Medtronic, Ethicon, B. Braun Melsungen AG, and Becton, Dickinson & Company lead through broad surgical portfolios and global distribution reach.

Tags:

  • Automated Suturing Devices
  • Automated Suturing Devices Mechanism
  • Automated Suturing Devices Companies
  • Automated Suturing Devices Medical devices

License Type


Offer

Request Sample

View Pricing

Customize Reports As Per Your Needs

Don't see what you're looking for? Get a report tailored to your specific requirements. Customize your report now!

Have a Question?

We are happy to assist you.

DelveInsight
DelveInsight
SUBSCRIPTION
Platform

Register for free trial today and gain instant access to 7000+ market
research reports